Drug intelligence / Profile preview

neomycin sulfate + bacitracin zinc + lidocaine hydrochloride + polymyxin b

Development stage
Approved
Lead developer
Kenvue
Modality
Small Molecules
Administration
Topical
01

Overview

Neomycin sulfate + bacitracin zinc + lidocaine hydrochloride + polymyxin b is an over-the-counter topical combination drug composed of three first-aid antibiotics plus a local anesthetic. Bacitracin inhibits bacterial cell wall synthesis, polymyxin B disrupts bacterial membrane integrity, neomycin is an aminoglycoside that inhibits bacterial protein synthesis, and lidocaine provides local analgesia through blockade of voltage-gated sodium channels. The product is marketed by multiple manufacturers in cream or ointment formulations for prevention of infection and temporary pain relief in minor cuts, scrapes, and burns; branded examples include RECELLTIS and Biotic-Plus. The exact strengths and excipients vary by manufacturer, so this name refers to a formulation class defined by the same active-ingredient combination rather than one single sponsor-specific asset.

Brand names
RECELLTISBiotic-Plus
Other names
neomycin sulfate + bacitracin zinc + lidocaine hydrochloride + polymyxin btriple antibiotic plus lidocainetriple antibiotic plus pain relief
02

Targets

UP (Undecaprenyl phosphate)NaV (Voltage-gated sodium channels)Bacterial RibosomeLipid A

Beyond the preview

Go deeper on neomycin sulfate + bacitracin zinc + lidocaine hydrochloride + polymyxin b.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neomycin sulfate + bacitracin zinc + lidocaine hydrochloride + polymyxin b.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call